Global Erectile Dysfunction Drugs Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 5942

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
North America held the largest share of the global erectile dysfunction drugs market in 2017. The U.S. is the largest pharmaceutical market in the world, and accounts for about 94% of the market in North America. The erectile dysfunction drugs market in the U.S. is driven by the availability of recognized branded formulations such as Viagra (sildenafil citrate), Cialis (tadalafil), and Levitra/Staxyn (vardenafil). However, the looming patent expiries of these branded drugs in the near future are expected to slightly alter this scenario by the end of the forecast period.

The global Erectile Dysfunction Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Erectile Dysfunction Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erectile Dysfunction Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Apricus Biosciences Inc.
Cristalia Produtos Quimicos Farmaceuticos Ltd.
Bayer AG
Dong-A Pharmaceutical Co. Ltd.
Meda Pharmaceuticals, Inc.
Eli Lilly and Company
Pfizer, Inc.
S.K. Chemicals Co. Ltd.
Vivus, Inc.

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Viagra (sildenafil citrate)
Cialis (tadalafil)
Levitra/Staxyn (vardenafil)
Stendra/Spedra (avanafil)
Zydena (udenafil)
Vitaros (Alprostadil Cream)
Others

Segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce

Table of Contents

Executive Summary
1 Erectile Dysfunction Drugs Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction Drugs
1.2 Erectile Dysfunction Drugs Segment by Type
1.2.1 Global Erectile Dysfunction Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Viagra (sildenafil citrate)
1.2.3 Cialis (tadalafil)
1.2.4 Levitra/Staxyn (vardenafil)
1.2.5 Stendra/Spedra (avanafil)
1.2.6 Zydena (udenafil)
1.2.7 Vitaros (Alprostadil Cream)
1.2.8 Others
1.3 Erectile Dysfunction Drugs Segment by Application
1.3.1 Erectile Dysfunction Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Drug Stores
1.3.5 Retail Pharmacies
1.3.6 E-Commerce
1.4 Global Erectile Dysfunction Drugs Market by Region
1.4.1 Global Erectile Dysfunction Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Erectile Dysfunction Drugs Market Size
1.5.1 Global Erectile Dysfunction Drugs Revenue (2014-2025)
1.5.2 Global Erectile Dysfunction Drugs Production (2014-2025)

2 Global Erectile Dysfunction Drugs Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Erectile Dysfunction Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Erectile Dysfunction Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Erectile Dysfunction Drugs Production Sites, Area Served, Product Types
2.5 Erectile Dysfunction Drugs Market Competitive Situation and Trends
2.5.1 Erectile Dysfunction Drugs Market Concentration Rate
2.5.2 Erectile Dysfunction Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Erectile Dysfunction Drugs Production Market Share by Regions
3.1 Global Erectile Dysfunction Drugs Production Market Share by Regions
3.2 Global Erectile Dysfunction Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Erectile Dysfunction Drugs Production
3.4.1 North America Erectile Dysfunction Drugs Production Growth Rate (2014-2019)
3.4.2 North America Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Erectile Dysfunction Drugs Production
3.5.1 Europe Erectile Dysfunction Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Erectile Dysfunction Drugs Production (2014-2019)
3.6.1 China Erectile Dysfunction Drugs Production Growth Rate (2014-2019)
3.6.2 China Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Erectile Dysfunction Drugs Production (2014-2019)
3.7.1 Japan Erectile Dysfunction Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Erectile Dysfunction Drugs Consumption by Regions
4.1 Global Erectile Dysfunction Drugs Consumption by Regions
4.2 North America Erectile Dysfunction Drugs Consumption (2014-2019)
4.3 Europe Erectile Dysfunction Drugs Consumption (2014-2019)
4.4 China Erectile Dysfunction Drugs Consumption (2014-2019)
4.5 Japan Erectile Dysfunction Drugs Consumption (2014-2019)

5 Global Erectile Dysfunction Drugs Production, Revenue, Price Trend by Type
5.1 Global Erectile Dysfunction Drugs Production Market Share by Type (2014-2019)
5.2 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Erectile Dysfunction Drugs Price by Type (2014-2019)
5.4 Global Erectile Dysfunction Drugs Production Growth by Type (2014-2019)

6 Global Erectile Dysfunction Drugs Market Analysis by Applications
6.1 Global Erectile Dysfunction Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Erectile Dysfunction Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Erectile Dysfunction Drugs Business
7.1 Apricus Biosciences Inc.
7.1.1 Apricus Biosciences Inc. Erectile Dysfunction Drugs Production Sites and Area Served
7.1.2 Erectile Dysfunction Drugs Product Introduction, Application and Specification
7.1.3 Apricus Biosciences Inc. Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Cristalia Produtos Quimicos Farmaceuticos Ltd.
7.2.1 Cristalia Produtos Quimicos Farmaceuticos Ltd. Erectile Dysfunction Drugs Production Sites and Area Served
7.2.2 Erectile Dysfunction Drugs Product Introduction, Application and Specification
7.2.3 Cristalia Produtos Quimicos Farmaceuticos Ltd. Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Bayer AG
7.3.1 Bayer AG Erectile Dysfunction Drugs Production Sites and Area Served
7.3.2 Erectile Dysfunction Drugs Product Introduction, Application and Specification
7.3.3 Bayer AG Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Dong-A Pharmaceutical Co. Ltd.
7.4.1 Dong-A Pharmaceutical Co. Ltd. Erectile Dysfunction Drugs Production Sites and Area Served
7.4.2 Erectile Dysfunction Drugs Product Introduction, Application and Specification
7.4.3 Dong-A Pharmaceutical Co. Ltd. Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Meda Pharmaceuticals, Inc.
7.5.1 Meda Pharmaceuticals, Inc. Erectile Dysfunction Drugs Production Sites and Area Served
7.5.2 Erectile Dysfunction Drugs Product Introduction, Application and Specification
7.5.3 Meda Pharmaceuticals, Inc. Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Erectile Dysfunction Drugs Production Sites and Area Served
7.6.2 Erectile Dysfunction Drugs Product Introduction, Application and Specification
7.6.3 Eli Lilly and Company Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Pfizer, Inc.
7.7.1 Pfizer, Inc. Erectile Dysfunction Drugs Production Sites and Area Served
7.7.2 Erectile Dysfunction Drugs Product Introduction, Application and Specification
7.7.3 Pfizer, Inc. Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 S.K. Chemicals Co. Ltd.
7.8.1 S.K. Chemicals Co. Ltd. Erectile Dysfunction Drugs Production Sites and Area Served
7.8.2 Erectile Dysfunction Drugs Product Introduction, Application and Specification
7.8.3 S.K. Chemicals Co. Ltd. Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Vivus, Inc.
7.9.1 Vivus, Inc. Erectile Dysfunction Drugs Production Sites and Area Served
7.9.2 Erectile Dysfunction Drugs Product Introduction, Application and Specification
7.9.3 Vivus, Inc. Erectile Dysfunction Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served

8 Erectile Dysfunction Drugs Manufacturing Cost Analysis
8.1 Erectile Dysfunction Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Erectile Dysfunction Drugs
8.4 Erectile Dysfunction Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Erectile Dysfunction Drugs Distributors List
9.3 Erectile Dysfunction Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Erectile Dysfunction Drugs Market Forecast
11.1 Global Erectile Dysfunction Drugs Production, Revenue Forecast
11.1.1 Global Erectile Dysfunction Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Erectile Dysfunction Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Erectile Dysfunction Drugs Price and Trend Forecast (2019-2025)
11.2 Global Erectile Dysfunction Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Erectile Dysfunction Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Erectile Dysfunction Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Erectile Dysfunction Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Erectile Dysfunction Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Erectile Dysfunction Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Erectile Dysfunction Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Erectile Dysfunction Drugs Consumption Forecast (2019-2025)
11.3.3 China Erectile Dysfunction Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Erectile Dysfunction Drugs Consumption Forecast (2019-2025)
11.4 Global Erectile Dysfunction Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Erectile Dysfunction Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer